2021 - Distinguished International Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH)
His scientific interests lie mostly in Immunology, Virology, Viral load, Internal medicine and Pre-exposure prophylaxis. Esper G. Kallas works mostly in the field of Virology, limiting it down to concerns involving Epitope and, occasionally, Viral replication. His Internal medicine study deals with Hiv incidence intersecting with Pediatrics, Transgender women and Dried blood.
Esper G. Kallas interconnects Cohort and Emtricitabine in the investigation of issues within Pre-exposure prophylaxis. He has researched Men who have sex with men in several fields, including Surgery, Incidence and Young adult. His research integrates issues of Chemoprophylaxis and Adverse effect in his study of Incidence.
His primary scientific interests are in Immunology, Virology, Immune system, CD8 and Viral load. Esper G. Kallas performs integrative study on Immunology and CD38 in his works. His Virology research incorporates elements of Epitope and Antibody.
The concepts of his CD8 study are interwoven with issues in T lymphocyte, Flow cytometry and Lymphocyte. His Viral load study integrates concerns from other disciplines, such as Internal medicine, Incidence and Cohort study. His Internal medicine study frequently involves adjacent topics like Endocrinology.
The scientist’s investigation covers issues in Immunology, Virology, Zika virus, Internal medicine and Antibody. In general Immunology, his work in CD8, Vaccination, Viral load and T cell is often linked to In patient linking many areas of study. His studies in Virology integrate themes in fields like Epitope, Human leukocyte antigen and Immune system.
His research investigates the connection between Zika virus and topics such as Outbreak that intersect with issues in Disease and Yellow fever. The study incorporates disciplines such as Pre-exposure prophylaxis and Oncology in addition to Internal medicine. His work investigates the relationship between Pre-exposure prophylaxis and topics such as Odds ratio that intersect with problems in Men who have sex with men.
The scientist’s investigation covers issues in Virology, Zika virus, Immunology, Dengue virus and Antibody. The various areas that Esper G. Kallas examines in his Virology study include Immune system and Coronavirus. His study in the field of CD8, Immunity, Viral load and Seroconversion is also linked to topics like Cutoff.
His Dengue virus study combines topics from a wide range of disciplines, such as Epitope, Antigen and GZMB. His studies deal with areas such as Virus, Fetus and Retrospective cohort study as well as Antibody. His Public health study combines topics in areas such as Men who have sex with men, Pre-exposure prophylaxis and Incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Robert M. Grant;Javier R. Lama;Peter L. Anderson;Vanessa McMahan.
The New England Journal of Medicine (2010)
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
Robert M. Grant;Robert M. Grant;Robert M. Grant;Peter L. Anderson;Vanessa McMahan;Albert Liu.
Lancet Infectious Diseases (2014)
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.
Peter L. Anderson;David V. Glidden;Albert Liu;Susan Buchbinder.
Science Translational Medicine (2012)
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.
David I Watkins;Dennis R Burton;Esper G Kallas;John P Moore.
Nature Medicine (2008)
No Evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis
Julia L. Marcus;David V. Glidden;Kenneth H. Mayer;Albert Y. Liu.
PLOS ONE (2013)
Circulating Follicular Helper–Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity
Jin Young Choi;John Hsi En Ho;Sandra G. Pasoto;Viviane Bunin.
Arthritis & Rheumatism (2015)
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
T. Christopher Mast;Lisa Kierstead;Swati B. Gupta;Alexander A. Nikas.
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
Madeline B Deutsch;David V Glidden;Jae Sevelius;Joanne Keatley.
The Lancet HIV (2015)
Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock.
Paulo Sergio Martins;Esper Georges Kallas;Miguel Cendoroglo Neto;Maria Aparecida Dalboni.
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
Ricardo Palacios;Elizabeth González Patiño;Roberta de Oliveira Piorelli;Monica Tilli Reis Pessoa Conde.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: